Announced Mon, 8 Sept · 19:07 IST

Annual Report under Regulation-34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) 2015 for the financial year ended 31st March 2025.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Panchsheel Organics Limited has submitted its Annual Report for the financial year ended 31st March 2025, along with the notice for its 36th Annual General Meeting (AGM) to be held on 30th September 2025 via video conferencing. The company is an ISO-certified, GMP-approved pharma manufacturer and exporter of Active Pharma Ingredients (APIs), intermediates, and formulations, with over three decades of experience and manufacturing units in Indore. The Board has recommended a final dividend of Rs. 0.80 per share (8%) for FY24-25. The AGM also seeks shareholder approval to appoint M/s. Vijay S. Tiwari & Associates as the new Secretarial Auditor for a five-year term (FY 2025-26 to FY 2029-30) and to regularize three additional directors.

Likely market impact

Routine annual compliance filing. The proposed 8% dividend is a positive signal for income-seeking shareholders, while the director appointments and secretarial auditor change reflect standard governance housekeeping with no material impact on stock price expected.